Norihiro Nakamura

Norihiro Nakamura

Company: BrightPath Biotherapeutics

Job title: Chief Scientific Officer


Targeted Inhibition of Adenosine-Pathway by Humanized Antibodies to Enhance the Cancer Immunity 10:00 am

• Understanding the rationale of the target • Highlighting the developing products and combination with checkpoint inhibition • Discussing the challenges for clinical developmentRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.